Lupus podocytopathy—Case series and review

Abstract

Get full access to this article

View all access options for this article.

References

Sakhi

Moktefi

Bouachi

, et al. Podocyte injury in lupus nephritis. J Clinical Medicine 2019; 8: 1340.

Oliva-Damaso

Payan

Oliva-Damaso

, et al. Lupus podocytopathy: an overview. Advances Chronic Kidney Disease 2019; 26: 369–375.

Han

Schwartz

Lewis

. Association of glomerular podocytopathy and nephrotic proteinuria in mesangial lupus nephritis. Lupus 2006; 15: 71–75.

Dube

Markowitz

Radhakrishnan

, et al. Minimal change disease in systemic lupus erythematosus. Clinical Nephrology 2002; 57: 120–126.

Rafael-Vidal

Altabás

Pérez

, et al. Calcineurin and systemic lupus erythematosus: the rationale for using calcineurin inhibitors in the treatment of lupus nephritis. International J Molecular Sciences 2021; 22: 1263.

Arriens

Polyakova

Adzerikho

, et al. Aurora Phase 3 Study demonstrates voclosporin statistical superiority over standard of care in Lupus Nephritis (LN). Annals of the Rheumatic Diseases 2020; 75: 819. https://ard.bmj.com/content/79/Suppl_1/172.2 (accessed on 19 December 2020).